Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi ponders which African health tech start-ups to bring to Paris

It's on the look out for those working in non-communicable diseases, telemedicine and HCP education

Sanofi

Sanofi is running a healthcare tech challenge competition for start-ups in Africa that are involved in the diagnosis of non-communicable diseases, telemedicine or chronic disease education for healthcare professionals.

The winners, whose tests will include showing positive results for their work in at least one African country, will join the pharma firm at the VivaTech 2018 conference in Paris in May.

VivaTech brings some 6,000 start-ups, investors, companies and tech leaders to the French capital, and will feature a Sanofi in Africa Lab.

Sanofi will later this month confirm which start-ups have been selected to come to VivaTech. It’s not the first year the pharma company has been involved with the event.

Now in its third outing, VivaTech will this year feature a booth dedicated to innovation in Africa, where up to 50 start-ups will pitch solutions they’ve developed.

Last year’s VivaTech saw Sanofi host start-ups involved in technologies such as artificial intelligence, robotics, the Internet of Things, 3D printing, big data and analytics.

5th March 2018

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics